Biography and Research Information
OverviewAI-generated summary
Abdul Rafae's research focuses on the pharmacological and clinical aspects of cancer treatment, with a particular emphasis on hematologic malignancies and lung cancer. His work involves systematic reviews and meta-analyses to evaluate the efficacy and safety of various therapeutic regimens. He has investigated treatments for multiple myeloma, including novel agents like belantamab mafodotin and carfilzomib-based regimens, as well as the role of venetoclax. Rafae also studies the combination of immunotherapy and chemotherapy for advanced non-small cell lung cancer. His publications address the management of ocular toxicity associated with oncological drugs and the efficacy of bispecific T-cell engager antibodies. He has also contributed to reviews on multicentric Castleman disease and transfusion strategies in acute myocardial infarction.
Metrics
- h-index: 10
- Publications: 73
- Citations: 471
Selected Publications
-
Efficacy and Safety Profile of Blinatumomab in Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R BCP-ALL) in Adults: A Systematic Review of Literature (2024)
-
A Systematic Review on Efficacy and Safety Profile of Blinatumomab in Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R BCP-ALL) in Children and Young Adults (2024)
-
Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis (2024)
-
Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients; A Scoping Review (2023)
-
Perspectives on the Treatment of Multiple Myeloma (2023)
-
Efficacy and Safety of Anti-Amyloid Antibodies in Patients with AL Amyloidosis: A Systematic Review of Literature (2022)
-
Copper deficiency, a rare but correctable cause of pancytopenia: a review of literature (2022)
Collaboration Network
Top Collaborators
Ahsan Wahab
Baptist Hospital (US)
14 shared publications
- Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma
- Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review
- The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma
Showing 5 of 14 shared publications
Hamid Ehsan
Levine Cancer Institute (US)
14 shared publications
- Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma
- Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review
- The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma
Showing 5 of 14 shared publications
Faiz Anwer
Cleveland Clinic (US)
11 shared publications
- Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: A systematic review
- Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients
- Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients; A Scoping Review
Showing 5 of 11 shared publications
Adeel Masood
Peninsula Regional Medical Center (US)
7 shared publications
- Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma
- Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma
- Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review
- Management of Myeloproliferative Neoplasms during Pregnancy: A Systematic Review
- Clinical outcomes and efficacy of endoscopic ultrasound guided ablation of pancreatic cancer a systematic review and a meta-analysis.
Showing 5 of 7 shared publications
Emad Kandah
McLaren Health Care (US)
7 shared publications
- The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Early presentation of pembrolizumab-associated pneumonitis
- Restrictive versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction: A Meta-Analysis of Randomized Clinical Trials
- Bispecific CART cells in the treatment of relapsed and refractory multiple myeloma: A review of literature.
Showing 5 of 7 shared publications
Karun Neupane
Jacobi Medical Center (US)
7 shared publications
- Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: A systematic review
- Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients
- Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review
- Management of Myeloproliferative Neoplasms during Pregnancy: A Systematic Review
- Clinical outcomes and efficacy of endoscopic ultrasound guided ablation of pancreatic cancer a systematic review and a meta-analysis.
Showing 5 of 7 shared publications
Muhammad Khawar Sana
John H. Stroger, Jr. Hospital of Cook County (US)
6 shared publications
- Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review
- Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma
- Electrolyte Abnormalities Associated With The Use of Atezolizumab – A Systematic Review
- Role of adjunct plasma exchange or high cut-off hemodialysis in the management of myeloma cast nephropathy: A systematic review.
- Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review
Showing 5 of 6 shared publications
Basel Abdelazeem
McLaren Health Care (US)
5 shared publications
- The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
- Restrictive versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction: A Meta-Analysis of Randomized Clinical Trials
- Role of adjunct plasma exchange or high cut-off hemodialysis in the management of myeloma cast nephropathy: A systematic review.
- Abstract 9870: Covid-19 is Associated with Increased In-Hospital Mortality in Patients Hospitalized for Acute Myocardial Infarction: A Meta-Analysis of Observational Studies
- Immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for non-small cell lung cancer: A systematic review and meta-analysis.
Joshua Christy
McLaren Regional Medical Center (US)
5 shared publications
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Early presentation of pembrolizumab-associated pneumonitis
- Bispecific CART cells in the treatment of relapsed and refractory multiple myeloma: A review of literature.
- Recent updates on three drug combination regimen for relapsed refractory multiple myeloma.
- Abstract 9870: Covid-19 is Associated with Increased In-Hospital Mortality in Patients Hospitalized for Acute Myocardial Infarction: A Meta-Analysis of Observational Studies
Mohammad Ebad Ur Rehman
Rawalpindi Medical University (PK)
5 shared publications
- Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: A systematic review
- Management of Myeloproliferative Neoplasms during Pregnancy: A Systematic Review
- Efficacy and Safety of Regimens Used for the Treatment of Multicentric Castleman Disease: A Systematic Review
- Recent Updates on Blinatumomab: A Bispecific T-Cell Engaging Antibody in Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia
- A Systematic Review on Efficacy and Safety Profile of Blinatumomab in Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R BCP-ALL) in Children and Young Adults
Tabinda Saleem
UPMC Central Pa (US)
4 shared publications
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Bispecific CART cells in the treatment of relapsed and refractory multiple myeloma: A review of literature.
- Recent updates on three drug combination regimen for relapsed refractory multiple myeloma.
- Recent Updates on Blinatumomab: A Bispecific T-Cell Engaging Antibody in Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia
Rabia Ali
Rawalpindi Medical University (PK)
4 shared publications
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Bispecific CART cells in the treatment of relapsed and refractory multiple myeloma: A review of literature.
- Recent updates on three drug combination regimen for relapsed refractory multiple myeloma.
- Recent Updates on Blinatumomab: A Bispecific T-Cell Engaging Antibody in Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia
Mustafa Nadeem Malik
4 shared publications
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Bispecific CART cells in the treatment of relapsed and refractory multiple myeloma: A review of literature.
- Recent updates on three drug combination regimen for relapsed refractory multiple myeloma.
- A Systematic Review on Efficacy and Safety Profile of Blinatumomab in Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R BCP-ALL) in Children and Young Adults
Sundas Ali
Saint Agnes Hospital (US)
4 shared publications
- Recent updates on bispecific T-cell engager (BiTE) antibodies in relapsed and refractory multiple myeloma.
- Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients
- Electrolyte Abnormalities Associated With The Use of Atezolizumab – A Systematic Review
- Recent Updates on Blinatumomab: A Bispecific T-Cell Engaging Antibody in Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia
Zahoor Ahmed
King Edward Medical University (PK)
4 shared publications
- Electrolyte Abnormalities Associated With The Use of Atezolizumab – A Systematic Review
- Management of Myeloproliferative Neoplasms during Pregnancy: A Systematic Review
- Clinical outcomes and efficacy of endoscopic ultrasound guided ablation of pancreatic cancer a systematic review and a meta-analysis.
- Efficacy and the safety of endoscopic ultrasound guided radiofrequency ablation of pancreatic cancer: A systematic review and meta-analysis.
Similar Researchers
Based on overlapping research topics
Abdul Rafae
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Tom Menzies
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Nishanth Thalambedu
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Mary Price
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Naveen Yarlagadda
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Meta-analysis and systematic reviews
Sravani Gundarlapalli
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies